Genomics Market

Industry Outlook

The global genomics market was worth US$ 13,122.9 million in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2018 to 2026. The exploration of genomics has been surpassed in the last three decades by massive technological advances that have allowed researchers to sequence larger pieces of the genome. Polymerase chain reaction (PCR) techniques, microarrays, and next-generation sequencing have made whole-genome sequencing cost-effective and highly efficient. These technological advancements have aided in various fields of applied biology, such as clinical genomics, drug discovery and development, and personalized medicine for various chronic diseases. For instance, genomics has revolutionized point-of-care testing across various infectious diseases, cancers, and congenital ailments, enabling the analysis of novel analytes, broad-spectrum analytical performances, and better turnaround times.

Various biotechnology companies have ventured into the market for genomics, changing the dynamics of the market. The cost of sequencing the human genome was estimated to be around $3 billion in 2003. However, Illumina, Inc.’s introduction of highly advanced next-generation sequencing products has significantly reduced the cost of human genome sequencing to $1,000.Thus, a dramatic decrease in the cost of sequencing and growing investments in biopharmaceutical research have driven the growth of the global genomics market. Projects such as the Human Genome Project, the Saudi Human Genome Program (SHGP), and the U.K. 100,000 Genome Project are further projected to drive the market for genomics worldwide. However, the huge investment and research infrastructure required for genomics research are some of the major restraining factors for the growth of this market.

Market Synopsis

Increased Adoption of NGS to Drive the Genomics Market

In 2017, the products segment held the largest share of the global genomics market. The product segment is further segmented by instrumentation technology and consumables/reagents sub-segments. The instrumentation technology segment is projected to grow at a significant rate during the forecast period owing to the high adoption of NGS platforms. Simplified NGS workflow, significant cost reductions for NGS instruments and reagents, and increased use of NGS in clinical applications such as oncology, genetic studies, and reproductive health will drive the market during the forecast period. With the advent of microarrays and microfluidics in point-of-care diagnostics and advancements in PCR and nucleic acid amplification technologies in DNA sequencing, the market will be further driven.

North America Dominated the Global Genomics Market

In 2017, North America held the largest share of the global genomics market owing to huge investments in genomic research by government institutions and growing awareness regarding genetic analysis, such as direct-to-consumer genetic testing, non-invasive prenatal testing, and another genetic testing in the region. Moreover, the growing number of budding biotechnology companies offering various genetic testing services in the region and the presence of major biopharmaceutical giants in the region further make North America the most lucrative market in the global genomics market. Asia Pacific is projected to witness the fastest growth during the forecast period owing to increasing genetic R&D activities and growing healthcare infrastructure focusing on genomic studies for drug discovery and disease treatment. Moreover, reducing the cost of genomics services and foreign investments in the region further drives the growth of the market.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The genomics market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product and service type, application, end-user, and geography.

The market is studied in order to understand the current dynamics and future trends in the global genomics market. The study includes market size and forecasts for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rates (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in the genomics market include Thermo Fisher Scientific, Inc.; Bio-Rad Technologies, Inc.; Illumina, Inc.; Danaher Corporation; BGI; Pacific Biosciences; Oxford Nanopore Technologies; and Myriad Genetics, Inc., among others. The companies are engaged in the launch of novel products and tools to maintain their position in the market. Mergers and acquisitions are an important growth strategy undertaken in the industry to keep a competitive edge in the market. For instance, Thermo Fisher Scientific acquired Life Technologies in 2016 to become the market leader in the genomics market.

Key questions are answered in this report.

• How will the global genomics market perform during the forecast period from 2018 to 2026?
• What are the latest trends in the genomics market and the most valuable opportunities for key players?
• Who are the leading players in the global genomics market?
• Which is the leading and fastest-growing region in the global genomics market?
• What are the drivers and restraints governing the global genomics market?
• What are the applications of genomics, and which is the currently leading application?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Genomics Market Portraiture
2.2. Global Genomics Market, by Product & Services Type, 2017 (US$ Mn)
2.3. Global Genomics Market, by Application, 2017 (US$ Mn)
2.4. Global Genomics Market, by End-User, 2017 (US$ Mn)
2.5. Global Genomics Market, by Geography, 2017 (US$ Mn)

Chapter 3. Genomics: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Driver 1
3.2.2. Driver 2
3.3. Challenges
3.3.1. Challenge 1
3.3.2. Challenge 2
3.4. Opportunities
3.4.1. Opportunity 1
3.4.2. Opportunity 2
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Genomics Market, by Key Players, 2017

Chapter 4. Global Genomics Market, by Product & Services Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Products
4.2.1. Instrumentation Technology
4.2.1.1. Sequencing Technology
4.2.1.2. Microarray
4.2.1.3. Polymerase Chain Reaction (PCR)
4.2.1.4. Nucleic Acid Extraction and Purification
4.2.1.5. Other Technologies
4.2.2. Consumables/Reagents
4.3. Services
4.3.1. Genomic Services
4.3.2. Sequencing Services
4.3.3. Data Analysis

Chapter 5. Global Genomics Market, by Application Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Disease Diagnostics
5.3. Drug Discovery
5.4. Personalized Medicine
5.5. Agriculture and Animal Research
5.6. Other Applications

Chapter 6. Global Genomics Market, by End-User Type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Academic and Government Research
6.3. Hospitals & Clinics
6.4. Biopharmaceutical Companies
6.5. Clinical Research

Chapter 7. Global Genomics Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. North America Genomics Market Analysis, 2016 – 2026
7.1.1. North America Genomics Market, by Product & Services Type, 2016 – 2026 (US$ Mn)
7.1.2. North America Genomics Market, by Application, 2016 – 2026 (US$ Mn)
7.1.3. North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
7.1.4. North America Genomics Market, by Country, 2016 – 2026 (US$ Mn)
7.1.4.1. U.S.
7.1.4.2. Canada
7.2. Europe Genomics Market Analysis, 2016 – 2026
7.2.1. Europe Genomics Market, by Product & Services Type, 2016 – 2026 (US$ Mn)
7.2.2. Europe Genomics Market, by Application, 2016 – 2026 (US$ Mn)
7.2.3. Europe Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
7.2.4. Europe Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific Genomics Market Analysis, 2016 – 2026
7.3.1. Asia Pacific Genomics Market, by Product & Services Type, 2016 – 2026 (US$ Mn)
7.3.2. Asia Pacific Genomics Market, by Application, 2016 – 2026 (US$ Mn)
7.3.3. North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
7.3.4. Asia Pacific Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America Genomics Market Analysis, 2016 – 2026
7.4.1. Latin America Genomics Market, by Product & Services Type, 2016 – 2026 (US$ Mn)
7.4.2. Latin America Genomics Market, by Application, 2016 – 2026 (US$ Mn)
7.4.3. North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
7.4.4. Latin America Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa Genomics Market, 2016 – 2026
7.5.1. Middle East & Africa Genomics Market, by Product & Services Type, 2016 – 2026 (US$ Mn)
7.5.2. Middle East & Africa Genomics Market, by Application, 2016 – 2026 (US$ Mn)
7.5.3. North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
7.5.4. Middle East & Africa Genomics Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa

Chapter 8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Agilent Technologies, Inc.
8.3. Bio-Rad Laboratories, Inc.
8.4. Merck KGaA
8.5. Danaher Corporation
8.6. GE Healthcare
8.7. BGI
8.8. Illumina, Inc.
8.9. Oxford Nanopore Technologies
8.10. Pacific Biosciences of California, Inc.
8.11. QIAGEN
8.12. Myriad Genetics, Inc.
8.13. Eurofins Scientific
8.14. 23nMe, Inc.

List of Figures

FIG 1. Genomics Market: Research Methodology
FIG 2. Genomics: Market Segmentation
FIG 3. Global Genomics Market, by Products & Services Type, 2017 (US$ Mn)
FIG 4. Global Genomics Market, by Application, 2017 (US$ Mn)
FIG 5. Global Genomics Market, by End-User, 2017 (US$ Mn)
FIG 6. Global Genomics Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Genomics Market, by Key Players, 2017
FIG 9. Global Sequencing Technology Market in Genomics, 2016-2026 (US$ Mn)
FIG 10. Global Microarray Market in Genomics, 2016-2026(US$ Mn)
FIG 11. Global Polymerase Chain Reaction (PCR) Market in Genomics, 2016-2026(US$ Mn)
FIG 12. Global ELISA Market in Genomics, 2016-2026(US$ Mn)
FIG 13. Global Nucleic Acid Extraction and Purification Market in Genomics, 2016-2026(US$ Mn)
FIG 14. Global Other Technologies Market in Genomics, 2016-2026(US$ Mn)
FIG 15. Global Consumables/Reagents Market in Genomics, 2016-2026(US$ Mn)
FIG 16. Global Genomic Services Market in Genomics, 2016-2026(US$ Mn)
FIG 17. Global Sequencing Services Market in Genomics, 2016-2026(US$ Mn)
FIG 18. Global Dana Analysis Market in Genomics, 2016-2026(US$ Mn)
FIG 19. Global Disease Diagnostics Market in Genomics, 2016-2026(US$ Mn)
FIG 20. Global Drug Discovery Market in Genomics, 2016-2026(US$ Mn)
FIG 21. Global Personalized Medicine Market in Genomics, 2016-2026(US$ Mn)
FIG 22. Global Agriculture and Animal Research Market in Genomics, 2016-2026(US$ Mn)
FIG 23. Global Other Applications Market in Genomics, 2016-2026(US$ Mn)
FIG 24. Global Academic and Government Research Market in Genomics, 2016-2026(US$ Mn)
FIG 25. Global Hospitals & Clinic Market in Genomics, 2016-2026(US$ Mn)
FIG 26. Global Biopharmaceutical Companies Market in Genomics, 2016-2026(US$ Mn)
FIG 27. Global Clinical Research Market in Genomics, 2016-2026(US$ Mn)
FIG 28. U.S. Genomics Market, 2016-2026 (US$ Mn)
FIG 29. Canada Genomics Market, 2016-2026 (US$ Mn)
FIG 30. U.K. Genomics Market, 2016-2026 (US$ Mn)
FIG 31. Germany Genomics Market, 2016-2026 (US$ Mn)
FIG 32. Rest of Europe Genomics Market, 2016-2026 (US$ Mn)
FIG 33. China Genomics Market, 2016-2026 (US$ Mn)
FIG 34. Japan Genomics Market, 2016-2026 (US$ Mn)
FIG 35. Rest of Asia Pacific Genomics Market, 2016-2026 (US$ Mn)
FIG 36. Brazil Genomics Market, 2016-2026 (US$ Mn)
FIG 37. Mexico Genomics Market, 2016-2026 (US$ Mn)
FIG 38. Rest of Latin America Genomics Market, 2016-2026 (US$ Mn)
FIG 39. GCC Genomics Market, 2016-2026 (US$ Mn)
FIG 40. Rest of Middle East & Africa Genomics Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Genomics Market Portraiture
TABLE 2 Global Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 5 Global Genomics Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 Global Products Market in Genomics, 2016-2026 (US$ Mn)
TABLE 7 Global Instrumentation Technology Market in Genomics, 2016-2026 (US$ Mn)
TABLE 8 Global Services Market in Genomics, 2016-2026 (US$ Mn)
TABLE 9 North America Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 10 North America Genomics Market, by Application , 2016 – 2026 (US$ Mn)
TABLE 11 North America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 12 North America Genomics Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Genomics Market, by Application Type, 2016 – 2026 (US$ Mn)
TABLE 15 Europe Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 16 Europe Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 24 Latin America Genomics Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East & Africa Genomics Market, by Component Type, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East & Africa Genomics Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East & Africa Genomics Market, by End-User, 2016 – 2026 (US$ Mn)
TABLE 28 Middle East & Africa Genomics Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 29 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 BGI: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Illumina, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Oxford Nanopore Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Pacific Biosciences of California, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 QIAGEN: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Myriad Genetics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 Eurofins Scientific: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 23nME, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)